These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 884875)
21. Negative correlation between neuropeptide Y profile in the cerebrospinal fluid and growth hormone pulses in the peripheral circulation in goats. Yonezawa T; Mogi K; Li JY; Sako R; Manabe N; Yamanouchi K; Nishihara M Neuroendocrinology; 2010; 91(4):308-17. PubMed ID: 20453462 [TBL] [Abstract][Full Text] [Related]
22. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type. Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823 [TBL] [Abstract][Full Text] [Related]
23. Immunoreactive somatostatin contents in the cerebrospinal fluid of children with various types of epilepsy. Nagaki S; Fukuyama Y; Kato N; Ikeda M; Higuchi T; Takahashi K; Naruse H Jpn J Psychiatry Neurol; 1988 Sep; 42(3):651-2. PubMed ID: 2907361 [No Abstract] [Full Text] [Related]
26. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981 [TBL] [Abstract][Full Text] [Related]
27. Development of a sensitive somatostatin radioimmunoassay and its application to plasma of stressed and non-stressed rats. Engelhardt W; Schwille PO Horm Metab Res; 1981 Jun; 13(6):318-23. PubMed ID: 6114917 [TBL] [Abstract][Full Text] [Related]
28. [Immunoreactive somatostatin]. Yanaihara N; Sato H; Yanaihara C; Sakura N; Shibazaki T Horumon To Rinsho; 1978 Jun; 26(6):545-51. PubMed ID: 99276 [No Abstract] [Full Text] [Related]
29. [The effect of synthetic somatostatin in normal and acromegalic males]. Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428 [TBL] [Abstract][Full Text] [Related]
30. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults. Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029 [TBL] [Abstract][Full Text] [Related]
31. [Somatostatin in the human cerebrospinal fluid--comparison with growth hormone-releasing factor]. Ogawa N Horumon To Rinsho; 1979 Jan; 27(1):77-9. PubMed ID: 371865 [No Abstract] [Full Text] [Related]
32. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose. Berelowitz M; Kronheim S; Pimstone B; Shapiro B J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602 [TBL] [Abstract][Full Text] [Related]
33. CSF somatostatin in multiple sclerosis: reversible loss of diurnal oscillation in relapses. Søorensen KV; Alslev T; Christensen SE; Jensen NB; Orskov H Neurology; 1987 Jun; 37(6):1050-3. PubMed ID: 2884594 [TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical demonstration of growth hormone, prolactin and somatostatin-like immunoreactivities in the brain of larval, young adult and upstream migrant adult sea lamprey, Petromyzon marinus. Wright GM Cell Tissue Res; 1986; 246(1):23-31. PubMed ID: 2877740 [TBL] [Abstract][Full Text] [Related]
35. The characterization of growth hormone release inhibiting hormone-like immunoreactivity in normal urine. Kronheim S; Berelowitz M; Pimstone BL Clin Endocrinol (Oxf); 1977 Oct; 7(4):343-7. PubMed ID: 923109 [TBL] [Abstract][Full Text] [Related]
36. Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: effect of environmental lighting. Arnold MA; Reppert SM; Rorstad OP; Sagar SM; Keutmann HT; Perlow MJ; Martin JB J Neurosci; 1982 Jun; 2(6):674-80. PubMed ID: 6123561 [TBL] [Abstract][Full Text] [Related]
37. A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution. Kronheim S; Berelowitz M; Pimstone BL Clin Endocrinol (Oxf); 1976 Nov; 5(6):619-30. PubMed ID: 1009674 [TBL] [Abstract][Full Text] [Related]
38. Human cerebrospinal fluid somatostatin in neurologic disease. Beal MF; Mazurek MF; Black PM; Martin JB J Neurol Sci; 1985 Nov; 71(1):91-104. PubMed ID: 2868070 [TBL] [Abstract][Full Text] [Related]
39. The presence of immunoreactive growth hormone release-inhibiting hormone in normal cerebrospinal fluid. Kronheim S; Berelowitz M; Pimstone BL Clin Endocrinol (Oxf); 1977 Jun; 6(6):411-5. PubMed ID: 884875 [TBL] [Abstract][Full Text] [Related]